This year, we continued on our three year journey of transformation to become the clear choice. We stimulated growth in our business, turned the spotlight back up on our Values and reflected on and communicated our Purpose
Tech Monitor UK is a joint report released by KPMG and Markit which looks at the health of the UK technology sector.
Explore why technology firms should choose to invest in the UK. We consider what the UK currently has in its favour as it battles for technology investment.
KPMG has recently published the 2014 Guide to Directors’ Remuneration, a survey which analyses trends in FTSE 350 directors’ pay.
We help our clients understand current issues and future trends in the world of work, and identify how they can enhance organisational performance through their people.
Explore the opportunities available for school and college leavers at KPMG.
Find out about careers for graduates from all degree disciplines in Audit, Tax, Advisory, Technology, Marketing and HR.
Keep up to date with the latest news and views from KPMG in the UK by following our twitter feed.
KPMG’s leadership blogs brings you insight, opinion and debate from our senior partners and industry experts.
Our new multi-media magazine for business leaders.
Our services are tailored to the issues that the industry ― and your company ― experience. Our professionals have already helped many companies with these issues:
KPMG’s industry-focused professionals have experience in the pharmaceutical sector; they continuously strive to keep abreast of industry trends, drivers and issues through knowledge sharing and industry insights programs. We also work closely with our Healthcare team to understand and deliver on the challenges around convergence.
Our global network aims to ensure that KPMG firms serve you with the same level of quality and consideration, whether you are operating in fast growing or emerging markets in the Americas, Asia or Europe.
In this KPMG report, we provide a factual description of the issues arising as a result of the complexities of the international tax systems and their impact on life sciences businesses and we propose four actions which life science companies should consider taking in the medium term.
KPMG’s new report Growing the pipeline, growing the bottom line: Shifts in pharmaceutical R&D innovation looks at the research challenge through the eyes of senior R&D executives from some of the world’s leading pharma companies.
More than medicine examines strategies and emerging opportunities life sciences companies can use to align their interests and expertise to evolving healthcare systems.
KPMG worked with the Association of the British Pharmaceutical Industry (ABPI) to publish a road map for the pharmaceutical industry. The four-point plan covers cross-industry recommendations which harness the potential of ‘big data’ to improve patient care and maximise the opportunities for investment in the UK.
UK and Global Head of Life Sciences
020 7311 8512
We can assist with the issues your business is facing and provide the services you require.
KPMG LLP, a UK limited liability partnership, and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative, a Swiss entity. All rights reserved.
KPMG International Cooperative ("KPMG International") is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.